Hold Time Study
Shouvik Mondal
Assistant Professor at ARKA JAIN University●Department of Pharmaceutics●Validation & Qualifiction●SAP●ERP●ALCOA+●DCS●QMS●21CFR Part11●CAPA●CC●Deviation●Presentation & Infographic Designer●Excel,PowerPoint,Word
INTRODUCTION
Hold time study provides the re-assurance of the quality at each in-process stages.
Hold Time Stability Study Flow in the Pharmaceutical Industry:
Hold time studies are performing during the product development, i.e scale up stage and commercial validation stages. Before starting the hold study, formulation scientist needs to select the critical stages (where the study is required), time points and tests. The flow of hold study has represented in the (Figure 1). In the pharmaceutical industry the hold study can be carried with the following steps.
i. Selection of critical steps
ii. Hold study time points and tests
iii. Hold study protocol
iv. Hold study analysis
v. Hold study report and
vi. Hold study results evaluation.
领英推荐
Hold Study Required Stages:
The selection of hold time stability study conditions is very important for starting the hold study. These conditions are same with the manufacturing area/hold area conditions, so these conditions are may vary with the product to product. Based on the manufacturing process of the dosage forms hold study stages can be decided. Hold study required stages are summarised in the table 1 . All pharmaceutical dosage forms hold study stages and study time requirements are discussed in detail like tablets, capsules, liquids, semi solids and injections.
STAGES, STUDY TIMES AND TESTS TO BE CONSIDERED:
Recommendations and Conclusion:
Hold study evaluation plays a main role for manufacturing the new products in GMP conditions. Based on the hold time study establishment and shelf life product manufacturing plan can be decided. If not performed the hold study in the product development stage then in commercial level need to perform the hold study for first three commercial batches . The conclusion should state whether the outcome of the activity was successful or not.
REVALIDATION:
The hold time study shall be performed again in case of any major change in product specification.
Consultant to FDA Regulated Industries
2 年https://law.justia.com/cases/federal/district-courts/FSupp/812/458/1762275/
Consultant to FDA Regulated Industries
2 年Shouvik, I disagree with a single lot providing sufficient data to support a Hold Study. Please review US v Barr Labs and the conclusions of Judge Wollin. I will suggest the use of 3 lots minimum. Each lot in the study should be made with different lots of the raw materials, including APIs. The study is not only to determine manufacturing hold time, but also consistency of the raw materials used in manufacturing the product within your process. I realize that you are referring to solid dose applications here, where powders have limited opportunities for change. But I’d look to changes in the environmental conditions, specifically humidity and the absorption of water by the dry powders, for instance. This absorption may affect size of the powder and potentially lead to mixing challenges. I am sure that if you think through these challenges, you will find the challenges that require validation with your process parameters. You can place some of these challenges within your QbD system and others within your process validation. The choice is yours. Good luck.